Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWeir Group Regulatory News (WEIR)

Share Price Information for Weir Group (WEIR)

Share Price is delayed by 15 minutes
Get Live Data
2,372.00    -66.00 (-2.71%)
Bid:
2,372.00
Ask:
2,376.00
Spread: 4.00 (0.169%)
Market Cap: £6.16b
WEIR Live PriceLast checked at - London Stock Exchange

Intraday Weir Group Share Chart

Trading Statement

18 Jan 2006 07:00

Weir Group PLC18 January 2006 18 January 2006 THE WEIR GROUP PLC TRADING UPDATE The Weir Group PLC issues a trading update in advance of its preliminaryannouncement for the 12 months ending 30 December 2005 due to be published on 21March 2006. Overall, on a like for like basis, turnover from continuing operations for thesecond half of the year will be more than 10% above the same period last yearand all divisions reported second half profits ahead of those achieved in thefirst half. Profit before tax, restructuring costs and discontinued operationsfor the 12 months ended 30 December 2005, will be ahead of last year and towardsthe upper end of Reuters market estimates. (See Footnote.) Cash generation remains healthy despite the effects of cash restructuring costs,share buy back and increased working capital employed to support the strongerorder book. Divisional Trading Comment Engineering Products In our Engineering Products Division we achieved good levels of growth in orderinput, sales and profits when compared to 2004. The Minerals businesses, as anticipated, continue to benefit from buoyant marketconditions and were major contributors to a strong second half financialperformance for the Engineering Products Division. The Clear Liquid businesses achieved good levels of order input in the secondhalf of the year. The results from Gabbioneta in the final quarter, and theongoing restructuring of the Weir Pumps business both contributed to the secondhalf improvement in the profitability of the Engineering Products Division. All Valves & Controls businesses delivered an improved performance in the secondhalf of the year. The restructuring of the UK operation is nearing completionand the early benefits are reflected in the last quarter figures. Engineering Services The Services Division delivered improved progress in turnover in the second halfwith profits slightly ahead of those achieved in the first half of the year. Thedivision has continued to fund investments for its future growth in its coremarkets. Defence, Nuclear & Gas The Defence, Nuclear and Gas Division continued to make progress in the secondhalf of the year with stronger sales and margins from both operations. Acontinued good level of enquiries, coupled with higher levels of sales, willfurther improve conditions in 2006. Outlook for 2006 The strong level of input growth in 2005 and strength of the year-end order bookis expected to translate to higher sales across all divisions in the first halfof 2006. Restructuring benefits will be evident in the improved marginperformance from the UK Valves & Clear businesses, while the addition ofGabbioneta will also contribute to further progress against 2005. Footnote: The profit range of analysts forecasts on Reuters Knowledge Consensus at 9 January 2006 was £57.50 m to £62.00 m with consensus at £59.50m. Contact details: The Weir Group PLCMark Selway, Chief Executive Tel. 0141 637 7111 (switchboard);Helen Walker, Public Relations Manager (Mobile: 07789 032296) The Maitland Consultancy Tel. 020 7379 5151Suzanne Bartch This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
18th Jun 202512:00 pmRNS-RWeir's Townley acquisition strengthens NA presence
17th Jun 202511:00 amRNSChange in external auditor
13th Jun 20253:49 pmRNSDirector/PDMR Shareholding
11th Jun 20257:00 amRNSWeir awarded £40m sustainable tailings contracts
3rd Jun 202510:44 amRNSDirector/PDMR Shareholding
23rd May 20252:29 pmRNSDirector/PDMR Shareholding
14th May 202511:43 amRNSDirector/PDMR Shareholding
12th May 202510:00 amRNS-RWeir and CiDRA announce collaboration agreement
9th May 20253:48 pmRNSDirector/PDMR Shareholding
30th Apr 20257:00 amRNSWeir completes acquisition of Micromine
25th Apr 20258:27 amRNSDirectorate Change
24th Apr 20254:25 pmRNSResult of AGM
24th Apr 20257:00 amRNSQ1 Trading Update
16th Apr 20253:19 pmRNSDirector/PDMR Shareholding
15th Apr 20255:00 pmRNSDirector/PDMR Shareholding
15th Apr 20254:58 pmRNSDirector/PDMR Shareholding
15th Apr 20254:56 pmRNSDirector/PDMR Shareholding
14th Apr 202510:24 amRNSDirector/PDMR Shareholding
14th Apr 202510:18 amRNSDirector/PDMR Shareholding
10th Apr 202512:28 pmRNSDirector/PDMR Shareholding
10th Apr 202512:28 pmRNSDirector/PDMR Shareholding
1st Apr 202511:20 amRNSDirector/PDMR Shareholding
1st Apr 202511:19 amRNSDirector/PDMR Shareholding
21st Mar 20251:46 pmRNS2024 Annual Report and 2025 Annual General Meeting
17th Mar 20251:07 pmRNSHolding(s) in Company
13th Mar 20251:58 pmRNSDirectorate Change
3rd Mar 20251:46 pmRNSDirector/PDMR Shareholding
28th Feb 202511:27 amRNSCLARIFICATION REGARDING ACQUISITION ANNOUNCEMENT
28th Feb 20257:01 amRNSAcquisition
28th Feb 20257:00 amRNSFinal Results
20th Nov 202410:13 amRNSHolding(s) in Company
5th Nov 20244:31 pmRNSDirector/PDMR Shareholding
5th Nov 20247:00 amRNSQ3 Trading Update
30th Sep 202412:31 pmRNSDirector/PDMR Shareholding
30th Sep 20247:00 amRNSWeir awarded £25m contract
11th Sep 20249:28 amRNSDirector/PDMR Shareholding
20th Aug 20247:00 amRNSWeir awarded £53m redefined flowsheet contract
30th Jul 20247:00 amRNSHalf-year Report
25th Jun 202411:28 amRNSHolding(s) in Company
3rd Jun 20245:24 pmRNSDirector/PDMR Shareholding
28th May 202412:03 pmRNSDirector/PDMR Shareholding
23rd May 20244:58 pmRNSDirector/PDMR Shareholding
15th May 20247:39 amRNSDirectorate Change
13th May 20249:54 amRNSHolding(s) in Company
25th Apr 20244:06 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Update
15th Apr 20245:21 pmRNSDirector/PDMR Shareholding
15th Apr 20244:28 pmRNSDirector/PDMR Shareholding
15th Apr 20244:19 pmRNSDirector/PDMR Shareholding
15th Apr 20244:18 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.